Treatment of Leptomeningeal Metastases Evaluated by Interphase Cytogenetics

Journal of Clinical Oncology- United States

doi 10.1200/jco.2000.18.10.2053

Full Text

Abstract

Available in

Date

Authors

Publisher

American Society of Clinical Oncology (ASCO)

Related search

Experimental Treatments for Leptomeningeal Metastases From Solid Malignancies

Cancer Control
MedicineOncologyHematology
2017English

Erratum To: Spinal Leptomeningeal Metastases From Prostate Cancer

Acta Neurochirurgica
SurgeryNeurology
2010English

Focal Management of Large Brain Metastases and Risk of Leptomeningeal Disease

Advances in Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2020English

Characteristics and Outcomes of Non-Hodgkin’s Lymphoma Patients With Leptomeningeal Metastases

International Journal of Clinical Oncology
MedicineSurgeryOncologyHematology
2018English

Complications Associated With Intraventricular Chemotherapy in Patients With Leptomeningeal Metastases

Journal of Neurosurgery
SurgeryNeurology
1997English

Interphase Cytogenetics for the Detection of the T(11;22)(q24;q12) in Small Round Cell Tumors.

Journal of Clinical Investigation
Medicine
1992English

Management of Leptomeningeal Metastases in Non-Oncogene Addicted Non-Small Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

Treatment of Pulmonary Colorectal Metastases by Radiofrequency Ablation

Clinical Colorectal Cancer
OncologyGastroenterology
2013English

Cauda Equina Syndrome Secondary to Leptomeningeal Metastases From Recurrent Primary Peritoneal Carcinoma

ecancermedicalscience
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy